Cardiac Failure Associated with Medical Therapy of Benign Prostatic Hyperplasia: A Population Based Study

Abstract

In routine care, men with a benign prostatic hyperplasia diagnosis and exposed to both 5-alpha reductase inhibitor and α-blocker therapy had an increased association with cardiac failure, with the highest risk for men exposed to nonselective α-blockers.